Completed PHASE1 INTERVENTIONAL 4-arm NCT04056130

A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects

A Phase I Randomized Double-blind Placebo-controlled Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects

Sponsor: KoBioLabs

Conditions Atopic Dermatitis (AD)

Interventions KBL697

Updated 8 times since 2019 Last updated: Sep 6, 2021 Started: Oct 4, 2019 Primary completion: Dec 23, 2019 Completion: Jan 7, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Atopic Dermatitis (AD), this trial is completed. The trial is conducted by KoBioLabs and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Oct 2021 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Oct 2021 [monthly]

Completed PHASE1
Mar 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed

▶ Show 3 earlier versions

Jan 2020 — Mar 2020 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting
Oct 2019 — Jan 2020 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Sep 2019 — Oct 2019 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

KoBioLabs
Novotech (Australia) Pty Limited

Data source: KoBioLabs

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia